CIBC Bancorp USA »

Denali Therapeutics shares owned by CIBC Bancorp USA

Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by CIBC Bancorp USA from 13F filings

Historical chart of CIBC Bancorp USA investment in Denali Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Denali Therapeutics held by CIBC Bancorp USA consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Denali Therapeutics by CIBC Bancorp USA

Quarter filed Position value Share count Share price at filing
2025-09-30 $205k 14k 14.52

More positions owned by CIBC Bancorp USA

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Mastercard Incorporated Cl A (MA)
Ishares Tr U.s. Real Es Etf (IYR)
Alphabet Cap Stk Cl C (GOOG)
JPMorgan Chase & Co. (JPM)
Tesla Motors (TSLA)
Linde SHS (LIN)
Cognizant Technology Solutio Cl A (CTSH)
Berkshire Hathaway Inc Del Cl B New (BRK.B)

View all positions for CIBC Bancorp USA

Top funds holding Denali Therapeutics

BlackRock
Vanguard Group
Baillie Gifford & Co
FMR
T. Rowe Price Investment Management
Ubs Global Asset Management Americas
State Street Corporation
Temasek Holdings
Capital Research Global Investors
Baker Bros. Advisors
Alliancebernstein
Geode Capital Management
Crestline Management
Holocene Advisors
Point72 Asset Management

View all funds holding Denali Therapeutics